Regulus Therapeutics Inc. IPO Advisory

IPO Research - IPO Boutique

<< Return Home

Subscribe Now
  IPO Boutique Blog
IPO Central
  IPO Calendar
  IPO Pipeline
  Track Record
  Last 10 IPO's & Quotes
  Sample IPO
  Rating Scale
  IPO Primer
Secondaries
  Current Week
  Track Record
  2015 Secondaries
  2014 Secondaries
  2013 Secondaries
  2012 Secondaries
  2011 Secondaries
  2010 Secondaries
  Secondaries Primer
Media
International publications
quoting IPO Boutique
founder Scott Sweet
General Info
  About Us
  Contact Us
  Testimonials
  Announcements
  Disclaimer
  Site Map
  A Touch of Humor



For IPO Boutique's "scale of 1 to 5" BUY rating on Regulus Therapeutics Inc., and our comprehensive analysis, click the "Buy Market Research" link.
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Regulus Therapeutics Inc.RGLS Last trade $18.47 $4.00 $4.734.3 million10/29/2014
Underwriter(s):
Deutsche Bank Securities, BMO Capital Markets
Co-Manager(s):
Needham & Co., Wedbush PacGrow Life Sciences, FBR
Filing(s):

Filed 2012-08-17

Regulus Therapeutics Inc. Historical Chart - Click chart for current quote

About Regulus Therapeutics Inc. (adapted from Regulus Therapeutics Inc. prospectus):
Regulus is a biopharmaceutical company focused on discovering and developing first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus uses their microRNA product platform to develop chemically modified, single-stranded oligonucleotides that they call anti-miRs. They use these anti-miRs to modulate microRNAs and by doing so return diseased cells to their healthy state.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.


Share this IPO Profile:

IPO Boutique aggregates information on public companies and private companies, such as "RGLS" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.



Need a recommendation? Visit our Testimonials page and see over 200 investors singing our praises.



Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2015 IPO Boutique. All Rights Reserved